Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Haem oxygenase 1 expression is associated with prognosis in cholangiocarcinoma patients and with drug sensitivity in xenografted mice
Sarinya Kongpetch, Anucha Puapairoj, Choon Kiat Ong, et al.
Cell Proliferation (2016) Vol. 49, Iss. 1, pp. 90-101
Open Access | Times Cited: 18

Showing 18 citing articles:

LncRNAs H19 and HULC, activated by oxidative stress, promote cell migration and invasion in cholangiocarcinoma through a ceRNA manner
Wentao Wang, Hua Ye, Panpan Wei, et al.
Journal of Hematology & Oncology (2016) Vol. 9, Iss. 1
Open Access | Times Cited: 228
HO-1 Induction in Cancer Progression: A Matter of Cell Adaptation
Mariapaola Nitti, Sabrina Piras, Umberto M. Marinari, et al.
Antioxidants (2017) Vol. 6, Iss. 2, pp. 29-29
Open Access | Times Cited: 190
Piperlongumine induces G2/M phase arrest and apoptosis in cholangiocarcinoma cells through the ROS-JNK-ERK signaling pathway
Sunisa Thongsom, Wipa Suginta, Kyung Jin Lee, et al.
APOPTOSIS (2017) Vol. 22, Iss. 11, pp. 1473-1484
Closed Access | Times Cited: 74
Clinical Significance of Heme Oxygenase 1 in Tumor Progression
Mariapaola Nitti, Caterina Ivaldo, Nicola Traverso, et al.
Antioxidants (2021) Vol. 10, Iss. 5, pp. 789-789
Open Access | Times Cited: 46
Heme Oxygenase-1 Has an Antitumor Role in Breast Cancer
Norberto A. Gandini, Eliana Noelia Alonso, María Eugenia Fermento, et al.
Antioxidants and Redox Signaling (2018) Vol. 30, Iss. 18
Open Access | Times Cited: 48
Nuclear Localization of Heme Oxygenase-1 in Pathophysiological Conditions: Does It Explain the Dual Role in Cancer?
Marilina Mascaró, Eliana Noelia Alonso, Exequiel G. Alonso, et al.
Antioxidants (2021) Vol. 10, Iss. 1, pp. 87-87
Open Access | Times Cited: 40
HO-1 drives autophagy as a mechanism of resistance against HER2-targeted therapies
Natasha Tracey, Helen Creedon, Alain J. Kemp, et al.
Breast Cancer Research and Treatment (2019) Vol. 179, Iss. 3, pp. 543-555
Open Access | Times Cited: 38
Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand
Sunitta Saensa‐Ard, Saman Leuangwattanawanit, Laddawan Senggunprai, et al.
Tumor Biology (2017) Vol. 39, Iss. 11, pp. 101042831772592-101042831772592
Open Access | Times Cited: 39
Heme Oxygenase-1 Inhibitors Induce Cell Cycle Arrest and Suppress Tumor Growth in Thyroid Cancer Cells
Po-Sheng Yang, Yi‐Chiung Hsu, Jie-Jen Lee, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 9, pp. 2502-2502
Open Access | Times Cited: 33
Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK-mTOR pathway
Jaroon Wandee, Auemduan Prawan, Laddawan Senggunprai, et al.
Life Sciences (2018) Vol. 207, pp. 172-183
Closed Access | Times Cited: 32
Protective effect of CDDO-ethyl amide against high-glucose-induced oxidative injury via the Nrf2/HO-1 pathway
Cun-Xin Zhang, Ting Wang, Jinfeng Ma, et al.
The Spine Journal (2017) Vol. 17, Iss. 7, pp. 1017-1025
Closed Access | Times Cited: 29
Metformin sensitizes cholangiocarcinoma cell to cisplatin-induced cytotoxicity through oxidative stress mediated mitochondrial pathway
Jaroon Wandee, Auemduan Prawan, Laddawan Senggunprai, et al.
Life Sciences (2018) Vol. 217, pp. 155-163
Closed Access | Times Cited: 25
Piperlongumine induces autophagy in biliary cancer cells via�reactive oxygen species-activated Erk signaling pathway
San‐Yuan Chen, Hsin‐Yi Huang, Han‐Pei Lin, et al.
International Journal of Molecular Medicine (2019)
Open Access | Times Cited: 25
Keap1 deletion accelerates mutant K-ras/p53-driven cholangiocarcinoma
Tatsuhide Nabeshima, Shin Hamada, Keiko Taguchi, et al.
AJP Gastrointestinal and Liver Physiology (2020) Vol. 318, Iss. 3, pp. G419-G427
Open Access | Times Cited: 16
Enhancement of piperlongumine chemosensitivity by silencing heme oxygenase‑1 expression in cholangiocarcinoma cell lines
Chutima Talabnin, Krajang Talabnin, Sopit Wongkham
Oncology Letters (2020) Vol. 20, Iss. 3, pp. 2483-2492
Open Access | Times Cited: 9
Iron cycle disruption by heme oxygenase-1 activation leads to a reduced breast cancer cell survival
G Giorgi, Marilina Mascaró, Norberto A. Gandini, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022) Vol. 1869, Iss. 3, pp. 166621-166621
Open Access | Times Cited: 6
Predictive and prognostic effect of HO-1 expression in breast cancer patients undergoing neoadjuvant chemotherapy
Qixing Tan, Qinghong Qin, Zhen Huang, et al.
Breast Cancer Research and Treatment (2022) Vol. 193, Iss. 2, pp. 393-403
Closed Access | Times Cited: 5
Inhibition of Heme Oxygenase 1 Suppresses Growth, Migration, and Invasion, and Regulates Tumor-Infiltrating CD8+ T Cells and in Uveal Melanoma
Chen Hou, Qi Wan, Lirong Xiao, et al.
Investigative Ophthalmology & Visual Science (2024) Vol. 65, Iss. 10, pp. 37-37
Open Access
Page 1

Scroll to top